These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20847405)

  • 1. ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients.
    Steinacker P; Klafki H; Lehnert S; Jesse S; Arnim CA; Tumani H; Pabst A; Kretzschmar HA; Wiltfang J; Otto M
    J Alzheimers Dis; 2010; 22(1):119-28. PubMed ID: 20847405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice].
    Blennow K; Lind B; Andersson E; Andreasen N
    Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
    Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
    Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease.
    Steinacker P; Rist W; Swiatek-de-Lange M; Lehnert S; Jesse S; Pabst A; Tumani H; von Arnim CA; Mitrova E; Kretzschmar HA; Lenter M; Wiltfang J; Otto M
    Proteomics; 2010 Jan; 10(1):81-9. PubMed ID: 19882659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
    Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
    Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
    Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
    Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
    Blennow K; Johansson A; Zetterberg H
    Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.
    Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I
    JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Cepek L; Steinacker P; Mollenhauer B; Wiese B; Ciesielczyk B; Bibl M; Wiltfang J; Zerr I; Schulz-Schaeffer W; Kretzschmar HA; Poser S; Otto M
    Dement Geriatr Cogn Disord; 2005; 19(5-6):376-82. PubMed ID: 15802913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.
    Skillbäck T; Rosén C; Asztely F; Mattsson N; Blennow K; Zetterberg H
    JAMA Neurol; 2014 Apr; 71(4):476-83. PubMed ID: 24566866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune activation markers neopterin and β2-microglobulin are not elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Stoeck K; Zerr I
    J Neuroimmunol; 2011 Apr; 233(1-2):228-32. PubMed ID: 21232804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form.
    Klafki HW; Lewczuk P; Kamrowski-Kruck H; Maler JM; Müller K; Peters O; Heuser I; Jessen F; Popp J; Frölich L; Wolf S; Prinz B; Luckhaus C; Schröder J; Pantel J; Gertz HJ; Kölsch H; Müller BW; Esselmann H; Bibl M; Kornhuber J; Wiltfang J
    J Alzheimers Dis; 2009; 18(3):613-22. PubMed ID: 19625747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.
    Jesse S; Steinacker P; Cepek L; von Arnim CA; Tumani H; Lehnert S; Kretzschmar HA; Baier M; Otto M
    J Alzheimers Dis; 2009; 17(3):541-51. PubMed ID: 19433893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
    Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
    Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronological changes in MRI and CSF biochemical markers in Creutzfeldt-Jakob disease patients.
    Satoh K; Shirabe S; Eguchi H; Tsujino A; Motomura M; Satoh A; Tsujihata M; Eguchi K
    Dement Geriatr Cogn Disord; 2007; 23(6):372-81. PubMed ID: 17389797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid.
    Collins S; Boyd A; Fletcher A; Gonzales M; McLean CA; Byron K; Masters CL
    J Clin Neurosci; 2000 May; 7(3):203-8. PubMed ID: 10833616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
    Bernheimer H; Gatterbauer B; Radbauer C; Budka H
    Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Wiltfang J; Esselmann H; Smirnov A; Bibl M; Cepek L; Steinacker P; Mollenhauer B; Buerger K; Hampel H; Paul S; Neumann M; Maler M; Zerr I; Kornhuber J; Kretzschmar HA; Poser S; Otto M
    Ann Neurol; 2003 Aug; 54(2):263-7. PubMed ID: 12891683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease.
    Wong BS; Green AJ; Li R; Xie Z; Pan T; Liu T; Chen SG; Gambetti P; Sy MS
    J Pathol; 2001 May; 194(1):9-14. PubMed ID: 11329135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.